Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection

Figure 1 Morphology of DCs treated with lamivudine (LAM) at different concentrations on the 8^th d (× 400). A: Non-LAM-treated DC; B: DC + LAM (0.125 mmol/L); C: DC + LAM (0.25 mmol/L); D: DC + LAM (0.5 mmol/L); E: DC + LAM (1 mmol/L); F: DC + LAM (2 mmol/L).

Figure 2 Modulation of cytokine secretion from DCs by LAM treatment. Bars indicate the levels of IL-12 (A) and IL-6 (B) in culture media of DCs treated with LAM at different concentrations (mean ± SD, n = 15).